Production of Solid Lipid Nanoparticles-Drug Loading and Release Mechanism
Solid lipid nanoparticles (SLNs)
introduced at the beginning of the 1990s represents an alternative carrier
system to traditional colloidal carriers, such as emulsions, liposomes and
polymeric micro and nanoparticles. A number of administration routes such as
topical, oral, parenteral, nasal and pulmonary have been proposed for the
delivery of SLNs. This paper reviews various production techniques for SLNs
including their advantages and disadvantages, drug incorporation, loading
capacity with the factors affecting drug incorporation and loading capacity and
drug release, especially emphasizing on mechanism drug release.
Comments
Post a Comment